{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:50:14Z","timestamp":1781092214260,"version":"3.54.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2314-B-350-001-MY3"],"award-info":[{"award-number":["MOST 106-2314-B-350-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2633-B-009-001"],"award-info":[{"award-number":["MOST 108-2633-B-009-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW106-TDU-B-211-113001"],"award-info":[{"award-number":["MOHW106-TDU-B-211-113001"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V105C-207, V106C-045, V108C-195, V109B-010, V109D50-003-MY3-1"],"award-info":[{"award-number":["V105C-207, V106C-045, V108C-195, V109B-010, V109D50-003-MY3-1"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cheng Hsin General Hospital and National Yang Ming Chiao Tung University","award":["CY113-11206-04 & CY 113-11206-05"],"award-info":[{"award-number":["CY113-11206-04 & CY 113-11206-05"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Beyond the well-established classical renin-angiotensin system (RAS), emerging evidence highlights the critical role of the non-classical RAS, specifically the Angiotensin (1\u20137)\/ACE2\/Mas axis. As the key enzyme converting Angiotensin II into Angiotensin (1\u20137), angiotensin-converting enzyme 2 (ACE2) exerts cardioprotective and anti-inflammatory effects, showing potential therapeutic value in critical care. This study investigates the association between circulating ACE2 levels and clinical outcomes in sepsis, offering insights into its role and potential for predicting sepsis outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Materials and methods<\/jats:title>\n<jats:p>In this single-center study, we investigated associations between the circulating ACE2 concentration and outcomes in septic patients admitted to a medical intensive care unit (ICU) between 01\/05\/2018 and 31\/01\/2021. Sepsis was defined as infection accompanied by a \u22652-point Sequential Organ Failure Assessment (SOFA) score increase. Patients were categorized into low (&lt;2.5\u2009ng\/mL) and high (\u22652.5\u2009ng\/mL) ACE2 groups based on serum concentrations within 24 hours of ICU admission. Outcomes comprised acute kidney injury (AKI), ICU mortality, and 90-day mortality.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>In total, 414 patients (mean age 68.5 years, 64.7% male) were included in the study. Elevated ACE2 levels correlated positively with SOFA score and total bilirubin and lactate concentrations, and negatively with the hemoglobin concentration. Relative to the low ACE2 group, the high ACE2 group was at increased risk of sepsis-associated AKI development within 48 hours after ICU admission (81.6% vs. 69.6%, <jats:italic><jats:italic>p<\/jats:italic><\/jats:italic> = 0.006), AKI requiring renal replacement therapy (21.3% vs. 11.1%, <jats:italic><jats:italic>p<\/jats:italic><\/jats:italic> = 0.007), ICU mortality (31.9% vs. 17.5%, <jats:italic><jats:italic>p<\/jats:italic><\/jats:italic> = 0.001), and 90-day mortality (51.7% vs. 39.6%, <jats:italic><jats:italic>p<\/jats:italic><\/jats:italic> = 0.018). Kaplan-Meier survival curves demonstrated significantly reduced survival in individuals with high ACE2 concentrations (<jats:italic><jats:italic>p<\/jats:italic><\/jats:italic> = 0.009). Univariate analysis revealed significant associations of high ACE2 concentrations with ICU mortality and AKI development within 48 hours after ICU admission. In a multivariate analysis adjusted for relevant variables, ACE2 elevation remained an independent predictor of ICU mortality (adjusted odds ratio 2.15, 95% confidence interval 1.04\u20134.41, <jats:italic><jats:italic>p<\/jats:italic><\/jats:italic> = 0.038).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Elevated circulating ACE2 concentrations comprised an independent predictor of ICU mortality, highlighting intricate RAS dynamics in critical illnesses. Low ACE2 concentrations were associated with greater survival, suggesting their potential as an early prognostic indicator.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0330668","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:28:21Z","timestamp":1756488501000},"page":"e0330668","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating angiotensin-converting enzyme 2 concentration is associated with acute kidney injury and mortality in sepsis"],"prefix":"10.1371","volume":"20","author":[{"given":"Ching-En","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2081-8419","authenticated-orcid":true,"given":"Ruey-Hsing","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsueh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1584-6749","authenticated-orcid":true,"given":"Po-Hsun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"2","key":"pone.0330668.ref001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill","volume":"35","author":"L Bitker","year":"2019","journal-title":"Crit Care Clin"},{"issue":"3","key":"pone.0330668.ref002","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"M de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"issue":"1","key":"pone.0330668.ref003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-018-2202-y","article-title":"Angiotensin converting enzyme defects in shock: implications for future therapy","volume":"22","author":"LS Chawla","year":"2018","journal-title":"Crit Care"},{"issue":"4","key":"pone.0330668.ref004","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/j.2040-4603.2012.tb00475.x","article-title":"Nonclassical renin-angiotensin system and renal function","volume":"2","author":"MC Chappell","year":"2012","journal-title":"Compr Physiol"},{"issue":"4","key":"pone.0330668.ref005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/SHK.0000000000000115","article-title":"Receptor MAS protects mice against hypothermia and mortality induced by endotoxemia","volume":"41","author":"LL Souza","year":"2014","journal-title":"Shock"},{"issue":"9","key":"pone.0330668.ref006","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/expphysiol.2011.056994","article-title":"Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology","volume":"96","author":"Y Qi","year":"2011","journal-title":"Exp Physiol"},{"issue":"6","key":"pone.0330668.ref007","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.112.191650","article-title":"Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice","volume":"59","author":"VB Patel","year":"2012","journal-title":"Hypertension"},{"issue":"10","key":"pone.0330668.ref008","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"SM Bindom","year":"2010","journal-title":"Diabetes"},{"issue":"12","key":"pone.0330668.ref009","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.3390\/jcm9124057","article-title":"SARS-CoV-2 and viral sepsis: immune dysfunction and implications in kidney failure","volume":"9","author":"A Stasi","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"pone.0330668.ref010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"A Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"8","key":"pone.0330668.ref011","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"pone.0330668.ref012","doi-asserted-by":"crossref","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"A Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"pone.0330668.ref013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2021.11.028","article-title":"Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients","volume":"115","author":"M Fagyas","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"7","key":"pone.0330668.ref014","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1016\/j.clnu.2021.06.004","article-title":"The paradox of the glycemic gap: Does relative hypoglycemia exist in critically ill patients?","volume":"40","author":"J-Y Guo","year":"2021","journal-title":"Clin Nutr"},{"issue":"4","key":"pone.0330668.ref015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","article-title":"Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians","volume":"55","author":"J Gauthier","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"pone.0330668.ref016","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/path.1670","article-title":"Renal ACE2 expression in human kidney disease","volume":"204","author":"AT Lely","year":"2004","journal-title":"J Pathol"},{"issue":"12","key":"pone.0330668.ref017","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/ki.2008.497","article-title":"Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease","volume":"74","author":"HN Reich","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"pone.0330668.ref018","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"HP Jia","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"pone.0330668.ref019","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1159\/000450564","article-title":"Overexpression of Intrarenal Renin-Angiotensin System in Human Acute Tubular Necrosis","volume":"41","author":"W Cao","year":"2016","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"pone.0330668.ref020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2215\/CJN.06280612","article-title":"Urinary angiotensinogen and risk of severe AKI","volume":"8","author":"JL Alge","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0330668.ref021","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"R Santos","year":"2018","journal-title":"Physiol Rev"},{"key":"pone.0330668.ref022","doi-asserted-by":"crossref","first-page":"104833","DOI":"10.1016\/j.phrs.2020.104833","article-title":"Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor","volume":"157","author":"Y Li","year":"2020","journal-title":"Pharmacol Res"},{"issue":"11","key":"pone.0330668.ref023","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/ndt\/gft320","article-title":"ACE2 alterations in kidney disease","volume":"28","author":"MJ Soler","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"pone.0330668.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071433","article-title":"Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury","volume":"8","author":"F Fang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"pone.0330668.ref025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000025959","article-title":"Effect of intrarenal infusion of angiotensin-(1-7) in the dog","volume":"23","author":"J Heller","year":"2000","journal-title":"Kidney Blood Press Res"},{"issue":"11","key":"pone.0330668.ref026","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2009.61","article-title":"Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria","volume":"75","author":"SVB Pinheiro","year":"2009","journal-title":"Kidney Int"},{"issue":"6","key":"pone.0330668.ref027","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II","volume":"46","author":"JA Tumlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"6","key":"pone.0330668.ref028","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","article-title":"Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup","volume":"19","author":"A Zarbock","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"pone.0330668.ref029","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial","volume":"202","author":"R Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"pone.0330668.ref030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.202010-3873LE","article-title":"Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3","volume":"203","author":"A Picod","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"pone.0330668.ref031","first-page":"1253","article-title":"Circulating dipeptidyl peptidase 3 modulates systemic and renal hemodynamics through cleavage of angiotensin peptides","volume":"202","author":"A Picod","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0330668.ref032","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-024-04910-6","article-title":"ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock","volume":"28","author":"DE Leisman","year":"2024","journal-title":"Crit Care"},{"issue":"1","key":"pone.0330668.ref033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.kint.2020.07.047","article-title":"Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury","volume":"99","author":"DE Leisman","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"pone.0330668.ref034","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1046\/j.1523-1755.2000.00416.x","article-title":"Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat","volume":"58","author":"J Zimpelmann","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"pone.0330668.ref035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13054-023-04518-2","article-title":"Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock","volume":"27","author":"N Pode-Shakked","year":"2023","journal-title":"Crit Care"},{"key":"pone.0330668.ref036","doi-asserted-by":"crossref","first-page":"103004","DOI":"10.1016\/j.redox.2023.103004","article-title":"Myeloid ACE2 protects against septic hypotension and vascular dysfunction through Ang-(1-7)-Mas-mediated macrophage polarization","volume":"69","author":"J-X Li","year":"2024","journal-title":"Redox Biol"},{"issue":"1","key":"pone.0330668.ref037","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/atm-22-6016","article-title":"Recombinant human angiotensin-converting enzyme 2 plays a protective role in mice with sepsis-induced cardiac dysfunction through multiple signaling pathways dependent on converting angiotensin II to angiotensin 1-7","volume":"11","author":"C Wu","year":"2023","journal-title":"Ann Transl Med"},{"issue":"1","key":"pone.0330668.ref038","doi-asserted-by":"crossref","DOI":"10.1186\/cc8887","article-title":"Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis","volume":"14","author":"KC Doerschug","year":"2010","journal-title":"Crit Care"},{"key":"pone.0330668.ref039","first-page":"1493","article-title":"Renin-angiotensin system in sepsis","volume":"9","author":"U Hilgenfeldt","year":"1987","journal-title":"Clin Exp Hypertens A"},{"issue":"5","key":"pone.0330668.ref040","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"W Zhang","year":"2014","journal-title":"Exp Ther Med"},{"issue":"1","key":"pone.0330668.ref041","doi-asserted-by":"crossref","first-page":"19848","DOI":"10.1038\/s41598-024-70587-0","article-title":"Circulating corin concentration is associated with risk of mortality and acute kidney injury in critically ill patients","volume":"14","author":"C-E Chen","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0330668.ref042","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"W Ni","year":"2020","journal-title":"Crit Care"},{"issue":"30","key":"pone.0330668.ref043","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in Cardiovascular and Kidney Diseases","volume":"24","author":"L Anguiano","year":"2017","journal-title":"Curr Med Chem"},{"issue":"1","key":"pone.0330668.ref044","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12882-020-01974-8","article-title":"Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis","volume":"21","author":"J Liu","year":"2020","journal-title":"BMC Nephrol"},{"issue":"2","key":"pone.0330668.ref045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","article-title":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications","volume":"30","author":"A Soro-Paavonen","year":"2012","journal-title":"J Hypertens"},{"key":"pone.0330668.ref046","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13293-017-0128-8","article-title":"Sex differences in the aging pattern of renin-angiotensin system serum peptidases","volume":"8","author":"A Fern\u00e1ndez-Atucha","year":"2017","journal-title":"Biol Sex Differ"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:28:29Z","timestamp":1756488509000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330668"}},"subtitle":[],"editor":[{"given":"Muhammad","family":"Iqhrammullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0330668","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}